Scott Becker retweeted
$LLY buyinng $MORF $3.2B - oral integrin for inflammatory bowel disease.
$57 per share. 78% premium.
prnewswire.com/news-releases…
Lab tip - BX795 @ 1uM can boost lentivirus transduction efficiency in hard to transduce cell lines by ~2.7x. We were inspired by this paper that showed BX795 boosts mammalian transfection efficiency. onlinelibrary.wiley.com/doi/…
1
7
538
After more repeats, we can't reproduce this anymore unfortunately. In fact we are now seeing that BX795 reduces transduction efficiencies and viability in some cell lines.
1
1
188
Transplus though from alstem seems to be working for Jurkat cell transduction - alstembio.com/web/product_de…
120
Scott Becker retweeted
Thrilled to announce that the California Public Utilities Commission just approved @Cruise for fared operation 24/7 across all of San Francisco!
It’s a huge milestone for the AV industry, but even more importantly a signal to the country that CA prioritizes progress over our tragic status quo.
We share the CPUC’s commitment to delivering safer, cleaner and more accessible transportation options, and remain committed to collaborating closely with regulators to push toward this critical goal.
Let’s Cruise!
Scott Becker retweeted
Today @TakedaPharma and Nimbus announced a definitive agreement under which Takeda will acquire Nimbus’ highly selective, allosteric TYK2 inhibitor: https://nitter.gq/t.co/R9yULDoeYu
"using predictive structures from AlphaFold alongside our structure refinement and drug design software potentially allows you to design a molecule that targets a family member of interest – in this case a signalling partner in the brain" 🤯
This Post is from an account that no longer exists. Learn more
Scott Becker retweeted
Just in case there's any doubt, the answer should be 'yes'!
ed.gr/tta1
Scott Becker retweeted
I have a massive trade deficit with the grocery store so I’ve decided to impose tariffs on Kroger
Scott Becker retweeted
Deep Chem is our effort to bridge the gap between modern Machine Learning methods and researchers in molecular sciences. V2.0 out today, more on the way. @deep_chem nitter.gq/rbhar90/status/9700621…
Selective mTORC1 Inhibitor just published by @NavitorPharma. This could be big. nitter.gq/NavitorPharma/status/9…
Our first scientific publication! A novel small molecule modulator of the GTP-binding protein Rheb which selectively inhibits the activation of mTORC1. Congrats to the team!:nature.com/articles/s41467-0…
1
Doesn't it violate SEC Regulation FD for public pharma companies to make their clinical trial result publications and presentations only available through a paywall? Is charging for something still making it publicly available?
3
Scott Becker retweeted
AlphaPoint Unveils New Blockchain Network, CEO Hire https://nitter.gq/t.co/asuuJqELlg
Scott Becker retweeted
“A Different Way — Thoughtful Financing, Or Why We Said ‘No’ to a Lot of Money” — @SachinKamdar muckhacker.com/a-different-w…
Scott Becker retweeted
Gilead offers a glimpse at hard data to back up its $600M investment in Nimbus’ NASH drug
$GILD
endpts.com/gilead-offers-a-g…
Airbnb founders are stealing money from the company. Paying essentially only themselves a dividend! This is legal?! nitter.gq/newsyc20/statuses/8399…
This Post is from a suspended account. Learn more
2
Mostly remote oncology trial completed nitter.gq/TSablinski/statuses/83…
transparencyls.com proud to lead transformation of oncology clinical research - tb presented at ASCO GU on Fri: abstracts.asco.org/197/AbstV…
Cards against humanity files for bankruptcy after failed Super Bowl ad nitter.gq/newsyc20/statuses/8285…
This Post is from a suspended account. Learn more















